Clinical Trial Update: Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial [Phase 2, Phase 3]

View source ↗

Summary

Randomized control trial investigating stroke prevention triggers in children with sickle cell anaemia at Mulago Hospital, Kampala (PREST) across Phase 2/Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Stroke Prevention in Pediatric Patients

Snippet

Sponsor: Makerere University | Conditions: Preventing Stroke in Sickle Cell Anaemia | Phase 2, Phase 3 | Status: UNKNOWN